All patients | Univariate analysis | ||
---|---|---|---|
Survivors | Non-survivors | P value | |
Variables | (n = 24) | (n = 8) | |
Age, year | 74 (65.5–79) | 66.5 (64.5–73) | 0.58 |
Female | 14 (58.3) | 4 (50) | 0.62 |
Male | 10 (41.7) | 4 (50) | |
Cancer | 16 (67) | 6 (75) | 0.69 |
CAD | 1 | 0 | |
Diabetes | 4 | 0 | |
Hypertension | 8 | 0 | |
Renal disease | 1 (4) | 3 (38) | 0.039 |
Observation period | 36 (24–46.5) | 20.5 (13.8–25.8) | 0.0069 |
Albumin (g l−1) | 19 (14.8–24) | 23 (13.8–28.3) | 0.406 |
CRP (mg l−1) | 11.5 (8.3–18) | 9.1 (5.4–15) | 0.809 |
WBC (× 109 l−1) | 6.3 (3.6–8.4) | 4.8 (3.8–6.8) | 0.552 |
Neutrophil count (× 109 l−1) | 5.3 (2.9–7.2) | 3.8 (3.2–4.9) | 0.454 |
Lymphocyte count (× 109 l−1) | 0.49 (0.36–0.78) | 0.31 (0.28–0.37) | 0.064 |
Plt count (× 104 mm−3) | 17.3 (15.2–23.2) | 21.1 (8.0–29) | 0.484 |